Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a ...

If you suffered losses exceeding $50,000 in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like ...

NEW YORK, NY / ACCESS Newswire / March 22, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders acquired 1,002 put options on the stock. This represents ...

Greetings. Welcome to Maravai LifeSciences Fourth Quarter 2024 Results Earnings Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal ...

Levi & Korsinsky, LLP notifies investors in Maravai LifeSciences Holdings, Inc. ("Maravai LifeSciences" or the "Company") of a class action securities ...

Represents additional corporate income taxes at an assumed effective tax rate of approximately 24% applied to additional net loss attributable to Maravai LifeSciences Holdings, Inc. from the ...

"Our fourth-quarter revenue landed near the midpoint of our guidance range, with the BST segment outperforming and NAP coming in slightly lower," said Trey Martin, CEO, Maravai LifeSciences.

NEW YORK, March 20, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of ...

Maravai Lifesciences Holdings Inc (MRVI) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and slightly lower revenue than anticipated. The company posted an adjusted ...

Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators ...